ZME Science
No Result
View All Result
ZME Science
No Result
View All Result
ZME Science

Home → Health → Diseases

US on track to approve more cancer drugs

Mihai AndreibyMihai Andrei
June 4, 2012
in Diseases, Health
A A
Share on FacebookShare on TwitterSubmit to Reddit

While a definite cure for cancer is still miles away, researchers and doctors are using more and more tactics to successfully corner the disease, and as a result, more and more cancer drugs are being developed and produced.

As we have a better understanding of the molecular makeup of the disease, novel techniques and treatments are being developed, including targeting specific gene mutations in tumors and harnessing the body’s own immune system to seek out and kill cancer cells.

“There are a large number of drugs being developed in oncology,” said Dr. Richard Pazdur, head of the FDA’s office of oncology products. “There is greater understanding of some of the disease processes.”

Last year, a third (10) of all newly approved drugs were for cancer. This year, the number is expected to grow.

“This year we expect over 20 oncology applications will be filed,” Pazdur said in an interview at a meeting of the American Society of Clinical Oncology in Chicago.

In terms of approval, some will take longer to study and evaluate, some will take longer to manufacture, while others will simply not be accepted. Still, some of them will be found on the shelves next year, when they will hopefully start saving lives.

“It is much easier to approve drugs that have greater efficacy,” Pazdur said. “Our staff is interested getting the drugs out earlier … it has to be drug that we really think is important.”

Cancer drugs are somewhat different from all others, due to the severity of the disease – the focus is more on efficiency rather than safety and caution.

“In oncology, the greatest difficulty has been the efficacy issue,” Pazdur said. “We are starting to see new drugs with important survival advantages.”

Still, that doesn’t mean that any drug that worked out in clinical trials will be a wonder once it hits the shelves; cancer is one of the most dangerous and tricky diseases, especially as the ethics of big pharma companies are sometimes questionable (Bayer bought prisoners in WWII, while Pfizer released 1 million faulty birth control pills). However, the FDA intends to improve the approval requirements, in order to prevent subjective trials.

RelatedPosts

The Arctic Seafloor Is Full of Life — And We’re About to Destroy It
What are Prions — the misfolded, confusing, and dangerous proteins
People who swear a lot are more f***ing honest
The surprisingly complex power dynamics of sugar dating. Here’s what psychologists found

“When we are seeing drugs with a high degree of efficacy — so-called ‘breakthrough’ drugs — it requires a different interaction with the companies,” Pazdur said. “We may change the registration strategy or the size of the trial.”

Via Reuters

ShareTweetShare
Mihai Andrei

Mihai Andrei

Dr. Andrei Mihai is a geophysicist and founder of ZME Science. He has a Ph.D. in geophysics and archaeology and has completed courses from prestigious universities (with programs ranging from climate and astronomy to chemistry and geology). He is passionate about making research more accessible to everyone and communicating news and features to a broad audience.

Related Posts

Invertebrates

The Worm That Outsourced Locomotion to Its (Many) Butts

byMihai Andrei
2 days ago
History

The unusual world of Roman Collegia — or how to start a company in Ancient Rome

byMihai Andrei
2 days ago
Merton College, University of Oxford. Located in Oxford, Oxfordshire, England, UK. Original public domain image from Wikimedia Commons
Bizarre Stories

For over 500 years, Oxford graduates pledged to hate Henry Symeonis. So, who is he?

byMihai Andrei
3 days ago
News

The Strongest Solar Storm Ever Was 500 Times More Powerful Than Anything We’ve Seen in Modern Times. It Left Its Mark in a 14,000-Year-Old Tree

byTibi Puiu
3 days ago

Recent news

The Worm That Outsourced Locomotion to Its (Many) Butts

May 16, 2025

The unusual world of Roman Collegia — or how to start a company in Ancient Rome

May 16, 2025
Merton College, University of Oxford. Located in Oxford, Oxfordshire, England, UK. Original public domain image from Wikimedia Commons

For over 500 years, Oxford graduates pledged to hate Henry Symeonis. So, who is he?

May 16, 2025
  • About
  • Advertise
  • Editorial Policy
  • Privacy Policy and Terms of Use
  • How we review products
  • Contact

© 2007-2025 ZME Science - Not exactly rocket science. All Rights Reserved.

No Result
View All Result
  • Science News
  • Environment
  • Health
  • Space
  • Future
  • Features
    • Natural Sciences
    • Physics
      • Matter and Energy
      • Quantum Mechanics
      • Thermodynamics
    • Chemistry
      • Periodic Table
      • Applied Chemistry
      • Materials
      • Physical Chemistry
    • Biology
      • Anatomy
      • Biochemistry
      • Ecology
      • Genetics
      • Microbiology
      • Plants and Fungi
    • Geology and Paleontology
      • Planet Earth
      • Earth Dynamics
      • Rocks and Minerals
      • Volcanoes
      • Dinosaurs
      • Fossils
    • Animals
      • Mammals
      • Birds
      • Fish
      • Amphibians
      • Reptiles
      • Invertebrates
      • Pets
      • Conservation
      • Animal facts
    • Climate and Weather
      • Climate change
      • Weather and atmosphere
    • Health
      • Drugs
      • Diseases and Conditions
      • Human Body
      • Mind and Brain
      • Food and Nutrition
      • Wellness
    • History and Humanities
      • Anthropology
      • Archaeology
      • History
      • Economics
      • People
      • Sociology
    • Space & Astronomy
      • The Solar System
      • Sun
      • The Moon
      • Planets
      • Asteroids, meteors & comets
      • Astronomy
      • Astrophysics
      • Cosmology
      • Exoplanets & Alien Life
      • Spaceflight and Exploration
    • Technology
      • Computer Science & IT
      • Engineering
      • Inventions
      • Sustainability
      • Renewable Energy
      • Green Living
    • Culture
    • Resources
  • Videos
  • Reviews
  • About Us
    • About
    • The Team
    • Advertise
    • Contribute
    • Editorial policy
    • Privacy Policy
    • Contact

© 2007-2025 ZME Science - Not exactly rocket science. All Rights Reserved.